145 related articles for article (PubMed ID: 32302762)
1. Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.
Al-Zubaydi F; Gao D; Kakkar D; Li S; Adler D; Holloway J; Szekely Z; Gu Z; Chan N; Kumar S; Love S; Sinko PJ
J Control Release; 2020 Jul; 323():71-82. PubMed ID: 32302762
[TBL] [Abstract][Full Text] [Related]
2. Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.
Al-Zubaydi F; Gao D; Kakkar D; Li S; Holloway J; Szekely Z; Chan N; Kumar S; Sabaawy HE; Love S; Sinko PJ
Drug Deliv Transl Res; 2022 Jan; 12(1):240-256. PubMed ID: 33590464
[TBL] [Abstract][Full Text] [Related]
3. Intraductal Drug Delivery to the Breast: Effect of Particle Size and Formulation on Breast Duct and Lymph Node Retention.
Joseph MK; Islam M; Reineke J; Hildreth M; Woyengo T; Pillatzki A; Baride A; Perumal O
Mol Pharm; 2020 Feb; 17(2):441-452. PubMed ID: 31886676
[TBL] [Abstract][Full Text] [Related]
4. The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity.
Gu Z; Gao D; Al-Zubaydi F; Li S; Singh Y; Rivera K; Holloway J; Szekely Z; Love S; Sinko PJ
Eur J Pharm Sci; 2018 Aug; 121():118-125. PubMed ID: 29698706
[TBL] [Abstract][Full Text] [Related]
5. Intraductal therapy of ductal carcinoma in situ: a presurgery study.
Mahoney ME; Gordon EJ; Rao JY; Jin Y; Hylton N; Love SM
Clin Breast Cancer; 2013 Aug; 13(4):280-6. PubMed ID: 23664819
[TBL] [Abstract][Full Text] [Related]
6. Intraductal delivery of nanocarriers for ductal carcinoma
Pandey M; Wen PX; Ning GM; Xing GJ; Wei LM; Kumar D; Mayuren J; Candasamy M; Gorain B; Jain N; Gupta G; Dua K
Nanomedicine (Lond); 2022 Oct; 17(24):1871-1889. PubMed ID: 36695306
[TBL] [Abstract][Full Text] [Related]
7. Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study.
Wang G; Chen C; Pai P; Korangath P; Sun S; Merino VF; Yuan J; Li S; Nie G; Stearns V; Sukumar S
Carcinogenesis; 2019 Jul; 40(7):903-913. PubMed ID: 31046118
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats.
Gu Z; Al-Zubaydi F; Adler D; Li S; Johnson S; Prasad P; Holloway J; Szekely Z; Love S; Gao D; Sinko PJ
J Interdiscip Nanomed; 2018 Sep; 3(3):146-159. PubMed ID: 30443411
[TBL] [Abstract][Full Text] [Related]
9. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems.
Ohtake T; Abe R; Kimijima I; Fukushima T; Tsuchiya A; Hoshi K; Wakasa H
Cancer; 1995 Jul; 76(1):32-45. PubMed ID: 8630874
[TBL] [Abstract][Full Text] [Related]
10. Intraductal Therapy in Breast Cancer: Current Status and Future Prospective.
Kuang XW; Liu JH; Sun ZH; Sukumar S; Sun SR; Chen C
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):133-143. PubMed ID: 32577880
[TBL] [Abstract][Full Text] [Related]
11. Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models.
Kenyon E; Zaluzec EK; Powell K; Volk M; Chakravarty S; Hix J; Arora R; Westerhuis JJ; Kiupel M; Shapiro EM; Sempere LF
J Vis Exp; 2022 Apr; (182):. PubMed ID: 35435915
[TBL] [Abstract][Full Text] [Related]
12. Intraductal Injections into the Mouse Mammary Gland.
Oliemuller E; Newman R; Howard BA
Methods Mol Biol; 2022; 2471():221-233. PubMed ID: 35175600
[TBL] [Abstract][Full Text] [Related]
13. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
Weir SJ; Dandawate P; Standing D; Bhattacharyya S; Ramamoorthy P; Rangarajan P; Wood R; Brinker AE; Woolbright BL; Tanol M; Ham T; McCulloch W; Dalton M; Reed GA; Baltezor MJ; Jensen RA; Taylor JA; Anant S
Cell Death Dis; 2021 May; 12(6):562. PubMed ID: 34059639
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ in rat mammary gland.
Crist KA; Chaudhuri B; Shivaram S; Chaudhuri PK
J Surg Res; 1992 Mar; 52(3):205-8. PubMed ID: 1311399
[TBL] [Abstract][Full Text] [Related]
16. X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models.
Kenyon E; Zaluzec E; Powell K; Volk M; Chakravarty S; Hix J; Kiupel M; Shapiro EM; Sempere LF
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36571406
[TBL] [Abstract][Full Text] [Related]
17. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
von Minckwitz G; Darb-Esfahani S; Loibl S; Huober J; Tesch H; Solbach C; Holms F; Eidtmann H; Dietrich K; Just M; Clemens MR; Hanusch C; Schrader I; Henschen S; Hoffmann G; Tiemann K; Diebold K; Untch M; Denkert C
Breast Cancer Res Treat; 2012 Apr; 132(3):863-70. PubMed ID: 21667238
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer.
Migotto A; Carvalho VFM; Salata GC; da Silva FWM; Yan CYI; Ishida K; Costa-Lotufo LV; Steiner AA; Lopes LB
Drug Deliv; 2018 Nov; 25(1):654-667. PubMed ID: 29495885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
